PT93170A - Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo um ingrediente activo - Google Patents

Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo um ingrediente activo

Info

Publication number
PT93170A
PT93170A PT93170A PT9317090A PT93170A PT 93170 A PT93170 A PT 93170A PT 93170 A PT93170 A PT 93170A PT 9317090 A PT9317090 A PT 9317090A PT 93170 A PT93170 A PT 93170A
Authority
PT
Portugal
Prior art keywords
active ingredient
capsules containing
distribution devices
piece
preparing distribution
Prior art date
Application number
PT93170A
Other languages
English (en)
Other versions
PT93170B (pt
Inventor
Marion Eileen Mcneill
Abdul Rashid
Howard Norman Ernest Stevens
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898903566A external-priority patent/GB8903566D0/en
Priority claimed from GB898921155A external-priority patent/GB8921155D0/en
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of PT93170A publication Critical patent/PT93170A/pt
Publication of PT93170B publication Critical patent/PT93170B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Massaging Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Surgical Instruments (AREA)
  • Molding Of Porous Articles (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Eye Examination Apparatus (AREA)
PT93170A 1989-02-16 1990-02-15 Processo para a preparacao de dispositivos distribuidores nomeadamente, de capsulas contendo um ingrediente activo PT93170B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898903566A GB8903566D0 (en) 1989-02-16 1989-02-16 Drug dispensing device
GB898921155A GB8921155D0 (en) 1989-09-19 1989-09-19 Drug dispensing device

Publications (2)

Publication Number Publication Date
PT93170A true PT93170A (pt) 1990-08-31
PT93170B PT93170B (pt) 1996-12-31

Family

ID=26294964

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93170A PT93170B (pt) 1989-02-16 1990-02-15 Processo para a preparacao de dispositivos distribuidores nomeadamente, de capsulas contendo um ingrediente activo

Country Status (18)

Country Link
EP (2) EP0458887A1 (pt)
JP (1) JPH0818971B2 (pt)
KR (1) KR0141473B1 (pt)
AT (1) ATE90202T1 (pt)
AU (1) AU629915B2 (pt)
CA (1) CA2047738C (pt)
DE (1) DE69001831T2 (pt)
DK (1) DK0384646T3 (pt)
ES (1) ES2043270T3 (pt)
FI (1) FI913880A0 (pt)
GB (1) GB2230442B (pt)
HU (1) HU207940B (pt)
IE (1) IE64761B1 (pt)
NO (1) NO303618B1 (pt)
NZ (1) NZ232561A (pt)
PT (1) PT93170B (pt)
RU (1) RU2104084C1 (pt)
WO (1) WO1990009168A1 (pt)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110597A (en) * 1987-06-25 1992-05-05 Alza Corporation Multi-unit delivery system
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
GB9004702D0 (en) * 1990-03-02 1990-04-25 Polysystems Limited Dispensing device
US5474784A (en) * 1990-03-02 1995-12-12 British Technology Group Limited Dispensing device
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
US5266325A (en) * 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
AU652984B2 (en) * 1992-01-14 1994-09-15 Endo Pharmaceuticals Solutions Inc. Preparation of homogeneous hydrogel copolymers
GB9223144D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Controlled release device
GB9223172D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
GB9223148D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule cap
GB9223146D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Vented capsule
CN1047075C (zh) * 1993-02-26 1999-12-08 普罗克特和甘保尔公司 比沙可啶剂型
JPH09500097A (ja) * 1993-04-20 1997-01-07 ティエスアールエル インコーポレイテッド 多段階薬剤供給装置
GB9320732D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled delivery of liquid
GB9320733D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled release device construction
EP0724441A1 (en) * 1993-10-19 1996-08-07 The Procter & Gamble Company Picosulphate dosage form
GB9323261D0 (en) * 1993-11-11 1994-01-05 Scherer Corp R P Dispensing device
US5516524A (en) * 1993-12-20 1996-05-14 The Procter & Gamble Company Laxative compositions containing bulk fiber
EP0758244B2 (en) * 1994-05-06 2008-02-13 Pfizer Inc. Controlled-release dosage forms of azithromycin
GB9718664D0 (en) 1997-09-04 1997-11-05 Scherer Corp R P Improvements in or relating to capsules
GB9724450D0 (en) * 1997-11-20 1998-01-14 Scherer Corp R P Delayed release device
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
US6303144B1 (en) 1998-02-10 2001-10-16 Welfide Corporation Preparations with controlled release
US6322819B1 (en) 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US6913768B2 (en) 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
WO2006009801A2 (en) 2004-06-17 2006-01-26 Valera Pharmaceuticals, Inc. Compositions and methods for treating central precocious puberty
CA2601304C (en) 2005-03-11 2010-08-17 Indevus Pharmaceuticals, Inc. Controlled release formulations of octreotide
DK1916995T4 (da) 2005-07-29 2022-10-03 Stichting Groningen Centre For Drug Res Ph-styret, pulserende indgivelsessystem, fremgangsmåder til fremstilling og anvendelse deraf
KR20120107533A (ko) 2005-11-28 2012-10-02 마리누스 파마슈티컬스 ｇａｎａｘｏｌｏｎｅ 제형, 이의 제조방법 및 용도
MX286464B (es) 2005-12-20 2011-05-10 Cenestra Llc Formulaciones de acido graso omega 3.
JP5479086B2 (ja) 2006-03-16 2014-04-23 トリス・フアルマ・インコーポレーテツド 薬剤−イオン交換樹脂複合体を含有する放出調節製剤
WO2008062320A2 (en) 2006-10-06 2008-05-29 Eisai R&D Management Co., Ltd Extended release formulations of a proton pump inhibitor
US9120249B2 (en) 2007-04-27 2015-09-01 Endo Pharmaceuticals Solutions Inc. Implant device release agents and methods of using same
JP5622725B2 (ja) 2008-06-25 2014-11-12 エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド．Ｅｎｄｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｓｏｌｕｔｉｏｎｓｉｎｃ． エキセナチド及び他のポリペプチド類の持続的送達
WO2009158415A1 (en) 2008-06-25 2009-12-30 Endo Pharmaceuticals Solutions Inc. Octreotide implant having a release agent
WO2010103367A1 (en) 2009-03-09 2010-09-16 Council Of Scientific & Industrial Research Pulsatile release composition of therapeutic agent
WO2015161139A1 (en) 2014-04-16 2015-10-22 Rapamycin Holdings, Llc Oral rapamycin preparation and use for stomatitis
US9731025B2 (en) 2010-08-20 2017-08-15 National University Corporation Tokyo Medical And Dental University Pharmaceutical composition for transcolonic absorption
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
DK4011364T3 (da) 2011-03-23 2024-03-18 Ironshore Pharmaceuticals & Dev Inc Fremgangsmåder og sammensætninger til behandling af ADD (Attention Deficit Disorder)
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
WO2013019891A1 (en) * 2011-08-01 2013-02-07 St. Hill Pharmaceutical Corporation Non-digestible capsules for the delivery of fluid absorbing materials
BR112014016550A8 (pt) * 2012-01-04 2017-07-04 Wellesley Pharmaceuticals Llc formulação de liberação retardada para reduzir a frequência de urinação e método de uso da mesma
US10278925B2 (en) 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
AU2013240427B2 (en) 2012-03-30 2017-08-03 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
AU2014373683B2 (en) 2013-12-31 2020-05-07 Rapamycin Holdings, Llc Oral rapamycin nanoparticle preparations and use
CA3254279A1 (en) 2015-06-03 2025-03-18 Triastek, Inc. PHARMACEUTICAL FORMS AND RELATED USES
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
EP3452003A4 (en) * 2016-05-05 2019-06-26 Triastek, Inc. DOSAGE FORM WITH CONTROLLED RELEASE
WO2018137686A1 (en) 2017-01-26 2018-08-02 Triastek, Inc. Dosage forms of controlled release at specific gastrointestinal sites
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
CN111698983B (zh) 2018-01-09 2022-10-18 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB436236A (en) * 1934-04-26 1935-10-08 Karl Wilhelm Schmidt Improvements in and relating to a therapeutic capsule
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
GB2112370B (en) * 1981-09-04 1984-09-26 Ciba Geigy Ag Inhibition of scale formation and corrosion in aqueous systems
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills

Also Published As

Publication number Publication date
NO303618B1 (no) 1998-08-10
NO913081D0 (no) 1991-08-08
AU5163290A (en) 1990-09-05
HUT58509A (en) 1992-03-30
GB2230442A (en) 1990-10-24
HU207940B (en) 1993-07-28
ES2043270T3 (es) 1993-12-16
PT93170B (pt) 1996-12-31
JPH04505004A (ja) 1992-09-03
FI913880A7 (fi) 1991-08-16
RU2104084C1 (ru) 1998-02-10
CA2047738A1 (en) 1990-08-17
IE64761B1 (en) 1995-09-06
EP0384646A1 (en) 1990-08-29
AU629915B2 (en) 1992-10-15
DK0384646T3 (da) 1993-07-12
WO1990009168A1 (en) 1990-08-23
ATE90202T1 (de) 1993-06-15
NZ232561A (en) 1992-02-25
GB9003503D0 (en) 1990-04-11
DE69001831T2 (de) 1993-09-16
EP0458887A1 (en) 1991-12-04
EP0384646B1 (en) 1993-06-09
JPH0818971B2 (ja) 1996-02-28
IE900556L (en) 1990-08-16
DE69001831D1 (de) 1993-07-15
KR920700617A (ko) 1992-08-10
FI913880A0 (fi) 1991-08-16
GB2230442B (en) 1992-11-25
HU902238D0 (en) 1991-11-28
CA2047738C (en) 2000-02-15
KR0141473B1 (en) 1998-06-01
NO913081L (no) 1991-08-08

Similar Documents

Publication Publication Date Title
PT93170A (pt) Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo um ingrediente activo
ES2010648T3 (es) Formulaciones farmaceuticas de sustancias labiles frente a los acidos para uso oral.
ES2006457A4 (es) Un procedimiento para la preparacion de una formulacion farmaceutica.
ES2059729T3 (es) Preparado farmaceutico de liberacion controlada y metodo para producir el mismo.
NO163356C (no) Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament.
DE69927963D1 (de) Gelierbare pharmazeutische zusammensetzungen
NO870558L (no) Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat.
DE60212534D1 (de) Wasserlösliche Packung enthaltend eine flüssige Zusammensetzung mit einer visuell unterscheidbaren Kapsel oder Emulsion oder Dispersionsschicht
DE58901990D1 (de) Feste pharmazeutische retardform.
PT93168A (pt) Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo ingredientes activos
DE69904954D1 (de) Verfahren zur herstellung neuer fenofibrathaltiger arzneiformulierungen, dadurch hergestellte arzneiformulierungen und ihre verwendung
ES2027005T3 (es) Procedimiento para preparar una formulacion farmaceutica de liberacion controlada de acrivastina.
EP0868912A3 (de) Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
DE58902457D1 (de) Retardierte arzneiform und verfahren zu ihrer herstellung.
AR009741A1 (es) Nuevos derivados de la benzamidina, procedimiento para prepararlos, preparados farmaceuticos que los contienen y su empleo como medicamentos.
SE8803822D0 (sv) Novel dosage form
MX5953E (es) Procedimiento mejorado para la produccion de pildoras para la liberacion controlada de productos quimicos biologicamente activos
FI822441A0 (fi) Pao xantinderivat baserade, magen icke irriterande laekemedelsprodukter och foerfarande foer deras framstaellning
DK0414115T3 (da) Hjælpemiddelfrie riboflavingranulater
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
ES516399A0 (es) "procedimiento para la fabricacion de productos farmaceuticos directamente absorbidos por el intestino delgado".
JPS5282715A (en) Long acting drug composition
ATE175870T1 (de) Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen
JPS54128575A (en) Novel pentalenonelactone compound and drugs comprising it as active constituent

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960903

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040331